HOOK vs. JAGX, TPST, RLYB, SCYX, ASMB, MRNS, IFRX, VTVT, MNOV, and SLS
Should you be buying Hookipa Pharma stock or one of its competitors? The main competitors of Hookipa Pharma include Jaguar Health (JAGX), Tempest Therapeutics (TPST), Rallybio (RLYB), SCYNEXIS (SCYX), Assembly Biosciences (ASMB), Marinus Pharmaceuticals (MRNS), InflaRx (IFRX), vTv Therapeutics (VTVT), MediciNova (MNOV), and SELLAS Life Sciences Group (SLS). These companies are all part of the "pharmaceutical preparations" industry.
Hookipa Pharma (NASDAQ:HOOK) and Jaguar Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, community ranking, analyst recommendations, media sentiment, profitability, institutional ownership and risk.
63.9% of Hookipa Pharma shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Health shares are owned by institutional investors. 5.8% of Hookipa Pharma shares are owned by insiders. Comparatively, 0.2% of Jaguar Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Hookipa Pharma has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Jaguar Health has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500.
Hookipa Pharma has a net margin of -88.73% compared to Jaguar Health's net margin of -377.95%. Hookipa Pharma's return on equity of -33.33% beat Jaguar Health's return on equity.
Hookipa Pharma presently has a consensus price target of $4.67, suggesting a potential upside of 472.32%. Given Hookipa Pharma's higher probable upside, analysts plainly believe Hookipa Pharma is more favorable than Jaguar Health.
Jaguar Health received 1750 more outperform votes than Hookipa Pharma when rated by MarketBeat users. Likewise, 89.08% of users gave Jaguar Health an outperform vote while only 69.11% of users gave Hookipa Pharma an outperform vote.
In the previous week, Jaguar Health had 5 more articles in the media than Hookipa Pharma. MarketBeat recorded 8 mentions for Jaguar Health and 3 mentions for Hookipa Pharma. Hookipa Pharma's average media sentiment score of 0.59 beat Jaguar Health's score of 0.14 indicating that Hookipa Pharma is being referred to more favorably in the media.
Jaguar Health has lower revenue, but higher earnings than Hookipa Pharma.
Summary
Hookipa Pharma beats Jaguar Health on 10 of the 15 factors compared between the two stocks.
Get Hookipa Pharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for HOOK and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HOOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Hookipa Pharma Competitors List
Related Companies and Tools